For the 28 blood specimens with a WBC count of > 30 x 109 cells/L included in the blood disorder study, it was possible to assess the impact of high WBC count on both the reference and point-of-care tests through depletion of the WBCs and measuring G6PD activity prior to and post depletion. The gene discussed is G6PD; the disease is hematologic disorder.